Olaparib 150mg Tablets

Olaparib 150mg is a PARP-inhibitor anticancer treatment for selected ovarian, breast, pancreatic or prostate cancers. Eligibility depends on the cancer setting, prior treatment and relevant tumour or inherited biomarkers.
Swallow tablets whole with water, with or without food. Do not crush, dissolve or split. Avoid grapefruit and Seville oranges. Skip a missed dose and resume the next scheduled dose.
Olaparib inhibits PARP-mediated DNA repair and traps PARP on DNA. Cancer cells with deficient homologous-recombination repair are especially vulnerable.
Nausea, fatigue, anaemia, vomiting, reduced appetite and diarrhoea can occur. Persistent low blood counts, new cough or breathlessness needs assessment.
Blood counts are checked before and during treatment. Strong or moderate CYP3A inhibitors can increase exposure. Rare marrow disorders and pneumonitis are important. Effective contraception is required because of fetal risk.
In eligible patients, PARP inhibition can delay progression or recurrence and extend disease control after an appropriate treatment response.
DNA-repair markers help identify cancer settings in which benefit is established. A cancer diagnosis alone does not determine eligibility.
No. The formulations differ in exposure and are not substituted milligram for milligram.
It can reduce olaparib exposure by inducing metabolism and should be avoided.
Anaemia is common during treatment. A blood count can help distinguish a treatment effect from other causes.
PARP: an enzyme involved in DNA repair. BRCA: genes involved in repair of DNA damage. Maintenance treatment: continuing treatment to prolong disease control.; AR: Olaparib 150mg أقراص; FR: Olaparib 150mg comprimés; PT: Olaparib 150mg comprimidos; ES: Olaparib 150mg comprimidos; RU: Olaparib 150mg таблетки; ID: Olaparib 150mg tablet; VI: Olaparib 150mg viên nén; MS: Olaparib 150mg tablet; TL: Olaparib 150mg mga tableta; ZH-SG: Olaparib 150mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Olaparib 150mg Tablets under Oncology Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Olaparib 150mg Tablets